Ducommun DCO
- Market cap
- $2.4B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 2.7×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $865.1M
- +9% on a year ago
- Net margin
- −2.5%
- Free cash flow yield
- −1.0%
Ducommun trades at 2.7× sales. Its trailing earnings are negative, so it has no PE. Revenue was $865.1M over the last twelve months, up 9% on a year earlier with a −2% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $196.3M+5% | $192.2M+2% | $191.7M+6% | $196.1M+5% | $201.4M+3% | $197.2M+3% | $192.5M+0% | $200.8M+2% | $214.4M+7% | $217.1M+10% | $209M+9% | $224.5M+12% | |
| Cost of revenue | $151.6M+3% | $150.5M+1% | $144.6M+0% | $145M−2% | $148.7M−2% | $150.8M+0% | $142M−2% | $147.8M+2% | $155.5M+5% | $157.9M+5% | $152.8M+8% | $161.6M+9% |
| Gross profit | $44.6M+16% | $41.7M+8% | $47.1M+28% | $51.1M+27% | $52.7M+18% | $46.4M+11% | $50.5M+7% | $53M+4% | $59M+12% | $59.2M+28% | $56.2M+12% | $62.9M+19% |
| SG&A | $32.2M+30% | $31M+19% | $33.1M+26% | $46.6M+53% | $35.3M+10% | $33.6M+9% | $45M+36% | $34.6M−26% | $34M−4% | $34.1M+1% | $40.5M−10% | $34.6M−0% |
| $8.6M−35% | $8.9M−8% | $12.6M+98% | $3.3M−34% | $15.4M+79% | $10.9M+22% | $5M−61% | $17.7M+438% | −$75.3M | $16.9M+55% | $15.7M+216% | $28.3M+60% | |
| Interest expense | $5.4M+79% | $5.4M+55% | $3.9M−8% | $4M−31% | $3.8M−29% | $3.6M−34% | $3.3M−16% | $3M−24% | $2.9M−24% | $3.5M−4% | $4M+23% | $3.5M+17% |
| Pre-tax income | $3.2M−67% | $3.8M−56% | $8.8M+45% | −$681K | $11.6M+258% | $7.2M+92% | $1.7M−80% | $16.5M | −$78.2M | $12.8M+77% | $11.7M+584% | $24.8M+51% |
| $26K−98% | −$1.3M | $2.4M+195% | −$5K | $2.2M+8342% | $662K | $310K−87% | $3.7M | −$17.4M | $3.5M+430% | $1.8M+479% | $4.4M+19% | |
| Net income | $3.2M−62% | $5.1M−37% | $6.4M+22% | −$676K | $9.4M+193% | $6.6M+29% | $1.4M−78% | $12.8M | −$60.8M | $9.3M+42% | $9.9M+607% | $20.4M+60% |
| $0.22−68% | $0.34−48% | $0.43+2% | −$0.05 | $0.63+186% | $0.44+29% | $0.09−79% | $0.84 | −$4.06 | $0.60+36% | $0.64+611% | $1.31+56% | |
| 14.8M+20% | 14.9M+20% | 14.9M+19% | 14.8M+9% | 15M+2% | 15.1M+1% | 15.2M+2% | 15.2M+3% | 15M−0% | 15.4M+2% | 15.6M+3% | 15.6M+2% |
Revenue: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them. 10 periods, Q2 FY10 to Q4 FY12: not printed by the filing, worked out from its own lines.
SG&A: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Operating income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Income tax: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Net income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
EPS, diluted: 7 periods, Q1 FY10 to Q4 FY23: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY10: share-days: the 6-month average less the second quarter's. 11 periods, Q4 FY10 to Q4 FY23: share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q4 FY11 to Q4 FY15: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Aerospace & Defense nearest Ducommun's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| DCODucommun | $2.4B | n/m | 24.0× | 2.7× | +9% | −2.5% | |
| ATROAstronics | $2.5B | 30.2× | 19.8× | 2.6× | +14% | 8.4% | |
| HOGHarley-Davidson | $3B | 17.8× | 11.9× | 0.7× | −5% | 4.8% | |
| THOThor Industries | $3.6B | 20.7× | 19.0× | 0.4× | +0% | 1.8% | |
| AIRAAR | $3.8B | 19.5× | 31.9× | 1.1× | +22% | 5.5% | |
| KRMNKarman | $4.9B | 126× | 206× | 8.2× | +50% | 6.3% | |
| LOARLoar | $5.8B | 85.5× | 104× | 9.8× | +30% | 11.6% | |
| WGOWinnebago Industries | $814.9M | 23.7× | 14.0× | 0.3× | −3% | 1.3% | |
| SAROStandardAero | $7.2B | 22.5× | 33.3× | 1.1× | +13% | 5.1% | |
| KTOSKratos Defense & Security Solutions | $7.3B | 228× | 177× | 4.8× | +26% | 2.0% | |
| RGRSturm Ruger | $726.5M | 60.6× | 17.4× | 1.3× | +8% | 2.1% | |
| Peer median | $3.7B | 26.9× | 25.8× | 1.2× | +14% | 5.0% |
More on Ducommun
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Aerospace & Defense
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .